{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:54:53Z","timestamp":1760028893384},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>A 39-year-old male patient with a favorable prognosis stage IIB metastatic malignant germ cell tumor (GCT) and elevated pre- and postorchiectomy serum human chorionic gonadotropin (hCG) was treated with three courses of combination chemotherapy resulting in a rapid normalization of his serum hCG.<\/jats:p>\n               <jats:p>Within 2 months after the cessation of chemotherapy, his serum hCG increased again, suggesting tumor recurrence. Pathological examination of the resected residual retroperitoneal lymph nodes revealed no vital tumor cells. Based on the further rise in his serum hCG and enlargement of mediastinal lymph nodes on computed tomography scan, the patient underwent second- and third-line chemotherapy, which did not result in normalization of his serum hCG. Reanalysis of stored serum samples with other immunoassays revealed that the elevated serum hCG levels collected before first-line chemotherapy were indeed elevated, but those collected after first-line chemotherapy were all falsely positive. Currently, the patient is still alive and disease free.<\/jats:p>\n               <jats:p>This is the first report of a male cancer patient who received unneeded second- and third-line chemotherapy for relapse based on false-positive hCG results. We discuss the pitfalls of false-positive serum hCG measurements, including heterophilic antibodies, as in our IgA-deficient patient, and review the literature.<\/jats:p>","DOI":"10.1634\/theoncologist.2008-0159","type":"journal-article","created":{"date-parts":[[2008,11,5]],"date-time":"2008-11-05T02:28:29Z","timestamp":1225852109000},"page":"1149-1154","source":"Crossref","is-referenced-by-count":21,"title":["False-Positive Serum Human Chorionic Gonadotropin (hCG) in a Male Patient with a Malignant Germ Cell Tumor of the Testis: A Case Report and Review of the Literature"],"prefix":"10.1093","volume":"13","author":[{"given":"Bart E.P.B.","family":"Ballieux","sequence":"first","affiliation":[{"name":"a Department of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir I.","family":"Weijl","sequence":"additional","affiliation":[{"name":"b Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[{"name":"b Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"van Pelt","sequence":"additional","affiliation":[{"name":"a Department of Clinical Chemistry, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Osanto","sequence":"additional","affiliation":[{"name":"b Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,11,4]]},"reference":[{"key":"2021122208574697900_R1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(00)01324-6","article-title":"False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations","volume":"355","author":"Rotmensch","year":"2000","journal-title":"Lancet"},{"key":"2021122208574697900_R2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinchem\/47.2.308","article-title":"Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases","volume":"47","author":"Cole","year":"2001","journal-title":"Clin Chem"},{"key":"2021122208574697900_R3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.clinbiochem.2004.03.001","article-title":"Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total \u03b2-hCG test","volume":"37","author":"Cole","year":"2004","journal-title":"Clin Biochem"},{"key":"2021122208574697900_R4","first-page":"423","article-title":"Inappropriate management of women with persistent low hCG results","volume":"49","author":"Cole","year":"2004","journal-title":"J Reprod Med"},{"key":"2021122208574697900_R5","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMc066500","article-title":"Normal production of human chorionic gonadotropin in menopause [letter]","volume":"356","author":"Cole","year":"2007","journal-title":"N Engl J Med"},{"key":"2021122208574697900_R6","volume-title":"Heterophilic Antibodies and False Positive hCG Test","author":"USA hCG Reference Service","year":"2008"},{"key":"2021122208574697900_R7","first-page":"843","article-title":"Falsely elevated human chorionic gonadotropin leading to unnecessary therapy","volume":"98","author":"Olsen","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2021122208574697900_R8","first-page":"1144","article-title":"Heterophile antibody blocking agent to confirm false positive serum human chorionic gonadotropin assay","volume":"101","author":"Esfandiari","year":"2003","journal-title":"Obstet Gynecol"},{"key":"2021122208574697900_R9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-5347(17)38465-3","article-title":"Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma","volume":"145","author":"van der Gaast","year":"1991","journal-title":"J Urol"},{"key":"2021122208574697900_R10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0090-4295(87)90247-0","article-title":"False positive beta-human chorionic gonadotropin in testicular cancer","volume":"30","author":"Mohler","year":"1987","journal-title":"Urology"},{"key":"2021122208574697900_R11","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0022-5347(05)67807-X","article-title":"Recognizing abnormal marker results that do not reflect disease in patients with germ cell tumors","volume":"163","author":"Morris","year":"2000","journal-title":"J Urol"},{"key":"2021122208574697900_R12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.ju.0000099714.16082.78","article-title":"Tumor marker levels in post-chemotherapy cystic masses: Clinical implications for patients with germ cell tumors","volume":"171","author":"Beck","year":"2004","journal-title":"J Urol"},{"key":"2021122208574697900_R13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000078336","article-title":"False-positive human serum chorionic gonadotropin in a patient with a history of germ cell cancer","volume":"66","author":"Trojan","year":"2004","journal-title":"Oncology"},{"key":"2021122208574697900_R14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(00)00066-0","article-title":"Limitations of tests for human chorionic gonadotropin [comment]","volume":"355","author":"Bagshawe","year":"2000","journal-title":"Lancet"},{"key":"2021122208574697900_R15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/S0140-6736(05)73128-7","article-title":"Needless treatment for presumed malignancy [letter]","volume":"355","author":"Price","year":"2000","journal-title":"Lancet"},{"key":"2021122208574697900_R16","first-page":"719","article-title":"False positive hCG [editorial]","volume":"98","author":"Hammond","year":"2001","journal-title":"Obstet Gynecol"},{"key":"2021122208574697900_R17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(02)00275-9","article-title":"Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays","volume":"325","author":"Levinson","year":"2002","journal-title":"Clin Chim Acta"},{"key":"2021122208574697900_R18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1373\/clinchem.2004.042994","article-title":"The war on heterophilic antibody interference [editorial]","volume":"51","author":"Bjerner","year":"2005","journal-title":"Clin Chem"},{"key":"2021122208574697900_R19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1373\/clinchem.2004.040501","article-title":"Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays","volume":"51","author":"Preissner","year":"2005","journal-title":"Clin Chem"},{"key":"2021122208574697900_R20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0277-5379(88)90113-7","article-title":"Tumor markers in non-malignant diseases","volume":"24","author":"Touitou","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2021122208574697900_R21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/clinchem\/36.1.164","article-title":"Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection","volume":"36","author":"Reinsberg","year":"1990","journal-title":"Clin Chem"},{"key":"2021122208574697900_R22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0022-1759(94)00301-C","article-title":"Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human\/mouse chimeric antibody to CEA as the tracer","volume":"180","author":"Kuroki","year":"1995","journal-title":"J Immunol Methods"},{"key":"2021122208574697900_R23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0009-9120(95)02044-6","article-title":"Different efficacy of various blocking reagents to eliminate interferences by human antimouse antibodies with a two-site immunoassay","volume":"29","author":"Reinsberg","year":"1996","journal-title":"Clin Biochem"},{"key":"2021122208574697900_R24","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/S0022-5347(05)65565-6","article-title":"Serum heterophile antibodies interfere with prostate specific antigen test and result in over treatment in a patient with prostate cancer","volume":"166","author":"Morgan","year":"2001","journal-title":"J Urol"},{"key":"2021122208574697900_R25","first-page":"414","article-title":"False elevation of serum CA-125 level caused by human anti-mouse antibodies","volume":"32","author":"Bertholf","year":"2002","journal-title":"Ann Clin Lab Sci"},{"key":"2021122208574697900_R26","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1210\/jc.2003-030122","article-title":"Phantoms in the assay tube: Heterophile antibody interferences in serum thyroglobulin assays","volume":"88","author":"Preissner","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122208574697900_R27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1373\/clinchem.2004.043349","article-title":"Effect of blood collection tubes on total triiodothyronine and other laboratory assays","volume":"51","author":"Bowen","year":"2005","journal-title":"Clin Chem"},{"key":"2021122208574697900_R28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1442-2042.2006.01648.x","article-title":"Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: Interference by human antimouse heterophile antibodies","volume":"14","author":"Park","year":"2007","journal-title":"Int J Urol"},{"key":"2021122208574697900_R29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2249.2005.02837.x","article-title":"Frequent false positive beta human chorionic gonadotropin tests in immunoglobulin A deficiency","volume":"141","author":"Knight","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"2021122208574697900_R30","first-page":"545","article-title":"Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer","volume":"49","author":"Cole","year":"2004","journal-title":"J Reprod Med"},{"key":"2021122208574697900_R31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.placenta.2007.01.011","article-title":"Hyperglycosylated hCG","volume":"28","author":"Cole","year":"2007","journal-title":"Placenta"},{"key":"2021122208574697900_R32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1634\/theoncologist.2007-0253","article-title":"False tumor marker surge evoked by peripheral blood stem cell transplantation","volume":"13","author":"Inoue","year":"2008","journal-title":"The Oncologist"},{"key":"2021122208574697900_R33","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1373\/clinchem.2005.055400","article-title":"Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720","volume":"51","author":"Bowen","year":"2005","journal-title":"Clin Chem"},{"key":"2021122208574697900_R34","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1373\/clinchem.2007.088518","article-title":"Increased human chorionic gonadotropin due to hypogonadism after treatment of a testicular seminoma [letter]","volume":"53","author":"Lempi\u00e4inen","year":"2007","journal-title":"Clin Chem"},{"key":"2021122208574697900_R35","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers","volume":"15","author":"International Germ Cell Cancer Collaborative Group","year":"1997","journal-title":"J Clin Oncol"},{"key":"2021122208574697900_R36","first-page":"317","volume-title":"Testis","author":"Greene","year":"2002","edition":"Sixth Edition"},{"key":"2021122208574697900_R37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.eururo.2007.12.025","article-title":"European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II","volume":"53","author":"Krege","year":"2008","journal-title":"Eur Urol"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2008-0159","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2008-0159","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/13\/11\/1149\/41832701\/oncolo_13_11_1149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/13\/11\/1149\/41832701\/oncolo_13_11_1149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T15:52:43Z","timestamp":1640188363000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/13\/11\/1149\/6397397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,1]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2008,11,4]]},"published-print":{"date-parts":[[2008,11,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2008-0159","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,11,1]]},"published":{"date-parts":[[2008,11,1]]}}}